产品说明
应用
Carmofur has been used as an inhibitor of acid ceramidase to study its effects on glucosylsphingosine (GlcSph) production in human embryonic kidney 293T (HEK293T) cells. It has also been used as an inhibitor of acid ceramidase to study its effects on acid‐mediated hydrolysis of ceramide which kicks-in consumption and the generation of sphingosine .
包装
10, 50 mg in glass bottle
生化/生理作用
Carmofur is a derivative of fluorouracil, an antimetabolite used as an antineoplastic agent.
Carmofur acts as an inhibitor of fatty acid amide hydrolase (FAAH), N-acylethanolamine acid amidase (NAAA) and acid ceramidase (ASAH1). Carmofur has a therapeutic activity against colorectal and cervical cancer. It can inhibit the severe acute respiratory syndrome (SARS)-CoV-2 main protease (Mpro) in vitro.
基本信息
| 经验(实验)分子式 | C11H16FN3O3 |
| 分子量 | 257.26 |
| MDL编号 | MFCD00866284 |
| PubChem化学物质编号 | 329774890 |
| NACRES | NA.77 |
产品性质
| 质量水平 | 100 |
| 测定 | ≥98% (HPLC) |
| 形式 | powder |
| 颜色 | white to off-white |
| 溶解性 | DMSO: >15 mg/mL |
| 储存温度 | 2-8℃ |
| SMILES string | CCCCCCNC(=O)N1C=C(F)C(=O)NC1=O |
| InChI | 1S/C11H16FN3O3/c1-2-3-4-5-6-13-10(17)15-7-8(12)9(16)14-11(15)18/h7H,2-6H2,1H3,(H,13,17)(H,14,16,18) |
| InChI key | AOCCBINRVIKJHY-UHFFFAOYSA-N |
安全信息
| 象形图 |   |
| 警示用语： | Danger |
| 危险声明 | H301 - H361 |
| 预防措施声明 | P201 - P301 + P310 + P330 |
| 危险分类 | Acute Tox. 3 Oral - Repr. 2 |
| 储存分类代码 | 6.1B - Non-combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
